Daniel Dlaboga

552 total citations
16 papers, 462 citations indexed

About

Daniel Dlaboga is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Daniel Dlaboga has authored 16 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 6 papers in Pharmacology. Recurrent topics in Daniel Dlaboga's work include Receptor Mechanisms and Signaling (10 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Neuroscience and Neuropharmacology Research (6 papers). Daniel Dlaboga is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Neuroscience and Neuropharmacology Research (6 papers). Daniel Dlaboga collaborates with scholars based in Poland, United States and United Kingdom. Daniel Dlaboga's co-authors include James M. O’Donnell, Marta Dziedzicka‐Wasylewska, Zofia Rogóż, Joanna Maj, Yunfeng Li, Lei Zhang, Han‐Ting Zhang, Marco Conti, Anbrin Masood and Ying Huang and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and Neuropsychopharmacology.

In The Last Decade

Daniel Dlaboga

16 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Dlaboga Poland 11 278 186 154 47 44 16 462
Takahide Shuto Japan 13 421 1.5× 344 1.8× 184 1.2× 47 1.0× 43 1.0× 24 697
Taiichiro Imanishi Japan 11 168 0.6× 208 1.1× 129 0.8× 38 0.8× 47 1.1× 17 422
Linda Ferrington United Kingdom 12 130 0.5× 188 1.0× 115 0.7× 79 1.7× 46 1.0× 22 464
Sophie M. Banas France 9 173 0.6× 259 1.4× 72 0.5× 65 1.4× 29 0.7× 16 480
Esa-Pekka Pälvimäki Finland 11 197 0.7× 295 1.6× 78 0.5× 39 0.8× 66 1.5× 12 440
Yuji Odagaki Japan 16 465 1.7× 494 2.7× 90 0.6× 46 1.0× 109 2.5× 69 713
Jesús Garcı́a-Colunga Mexico 16 476 1.7× 293 1.6× 89 0.6× 50 1.1× 18 0.4× 42 682
Bernadett K. Szász Hungary 10 153 0.6× 212 1.1× 72 0.5× 53 1.1× 34 0.8× 11 361
Manuelle Touzard France 11 320 1.2× 452 2.4× 65 0.4× 27 0.6× 107 2.4× 14 637
Christopher Cottingham United States 11 182 0.7× 164 0.9× 42 0.3× 50 1.1× 30 0.7× 18 337

Countries citing papers authored by Daniel Dlaboga

Since Specialization
Citations

This map shows the geographic impact of Daniel Dlaboga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Dlaboga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Dlaboga more than expected).

Fields of papers citing papers by Daniel Dlaboga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Dlaboga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Dlaboga. The network helps show where Daniel Dlaboga may publish in the future.

Co-authorship network of co-authors of Daniel Dlaboga

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Dlaboga. A scholar is included among the top collaborators of Daniel Dlaboga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Dlaboga. Daniel Dlaboga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Irvine, Mark W., Daniel Dlaboga, Richard P. Hulse, et al.. (2011). Piperazine-2,3-dicarboxylic Acid Derivatives as Dual Antagonists of NMDA and GluK1-Containing Kainate Receptors. Journal of Medicinal Chemistry. 55(1). 327–341. 19 indexed citations
2.
Fil, Daniel, et al.. (2009). Phosphodiesterase 4B2 gene is an effector of Toll-like receptor signaling in astrocytes. Metabolic Brain Disease. 24(3). 481–491. 6 indexed citations
3.
Dlaboga, Daniel, et al.. (2007). Chronic haloperidol and clozapine produce different patterns of effects on phosphodiesterase-1B, -4B, and -10A expression in rat striatum. Neuropharmacology. 54(4). 745–754. 30 indexed citations
4.
Zhang, Han‐Ting, Ying Huang, Anbrin Masood, et al.. (2007). Anxiogenic-Like Behavioral Phenotype of Mice Deficient in Phosphodiesterase 4B (PDE4B). Neuropsychopharmacology. 33(7). 1611–1623. 147 indexed citations
5.
Dlaboga, Daniel, et al.. (2006). Regulation of phosphodiesterase-4 (PDE4) expression in mouse brain by repeated antidepressant treatment: Comparison with rolipram. Brain Research. 1096(1). 104–112. 61 indexed citations
6.
Rogóż, Zofia, Andrzej Wróbel, Daniel Dlaboga, & Marta Dziedzicka‐Wasylewska. (2003). Effect of repeated treatment with mirtazapine on the central dopaminergic D2/D3 receptors.. PubMed. 54(4). 381–9. 8 indexed citations
7.
Przegaliński, Edmund, et al.. (2003). Withdrawal from chronic cocaine up-regulates 5-HT1B receptors in the rat brain. Neuroscience Letters. 351(3). 169–172. 30 indexed citations
8.
Rogóż, Zofia, Daniel Dlaboga, & Marta Dziedzicka‐Wasylewska. (2003). Effect of combined treatment with imipramine and amantadine on the central dopamine D2 and D3 receptors in rats.. PubMed. 54(2). 257–70. 11 indexed citations
9.
Dziedzicka‐Wasylewska, Marta, Zofia Rogóż, G Skuza, Daniel Dlaboga, & Joanna Maj. (2002). Effect of repeated treatment with tianeptine and fluoxetine on central dopamine D2/D3 receptors. Behavioural Pharmacology. 13(2). 127–138. 30 indexed citations
10.
Dziedzicka‐Wasylewska, Marta, et al.. (2002). Effect of tianeptine and fluoxetine on the levels of Met-enkephalin and mRNA encoding proenkephalin in the rat.. PubMed. 53(1). 117–25. 19 indexed citations
11.
Wróbel, Andrzej, et al.. (2002). Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors.. PubMed. 53(1). 105–16. 16 indexed citations
12.
Rogóż, Zofia, G Skuza, Daniel Dlaboga, Joanna Maj, & Marta Dziedzicka‐Wasylewska. (2001). Effect of repeated treatment with tianeptine and fluoxetine on the central α1-adrenergic system. Neuropharmacology. 41(3). 360–368. 31 indexed citations
13.
Dziedzicka‐Wasylewska, Marta, et al.. (2001). Some behavioural effects of antidepressant drugs are time-dependent. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 25(2). 373–393. 7 indexed citations
14.
Rogóż, Zofia, et al.. (2001). Effect of repeated treatment with milnacipran on the central dopaminergic system.. PubMed. 52(2). 83–92. 6 indexed citations
15.
Maj, Joanna, Zofia Rogóż, Daniel Dlaboga, & Marta Dziedzicka‐Wasylewska. (2000). Pharmacological effects of milnacipran, a new antidepressant, given repeatedly on the α 1 -adrenergic and serotonergic 5-HT 2A systems. Journal of Neural Transmission. 107(11). 1345–1359. 32 indexed citations
16.
Dlaboga, Daniel, R. Bartel, K. Bieniarz, & P. Epler. (1998). RELATION BETWEEN EGG SIZE AND BODY SIZE AND AGE OF FEMALES IN BROOK TROUT (Salvelinus fontinalis Mitchill). 6(1). 27–35. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026